Implanet S.A. (EPA:ALIMP)

Market Cap	19.67M -34.7%
Revenue (ttm)	13.80M +24.3%
Net Income	-4.43M
EPS	-0.03
Shares Out	143.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,402
Open	0.1368
Previous Close	0.1300
Day's Range	0.1350 - 0.1368
52-Week Range	0.1280 - 0.2860
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 49
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2025, Implanet's revenue was 12.47 million, an increase of 32.62% compared to the previous year's 9.41 million. Losses were -4.38 million, 0.37% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error